BackChennai Meenakshi Multispeciality Hospital Limited Overview

Chennai Meenakshi Multispeciality Hospital Limited EBIT

Chennai Meenakshi Multispeciality Hospital Limited's EBIT is $-5.2M, below the sector sector average of $2.4T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$2.32M
↓ 165.13% YoY

As of Sep 30, 2026

Annual EBIT (TTM)

-$5.15M
↓ 734.68% YoY

Trailing 12 months ending Sep 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Chennai Meenakshi Multispeciality Hospital Limited (CMMHOSP.BO) FAQ

Chennai Meenakshi Multispeciality Hospital Limited's ebit stands at $-5.2M as of September 2026. That compares with $-620K in the prior-year period — down 734.7% year over year. That is below the sector sector average of $2.4T. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Chennai Meenakshi Multispeciality Hospital Limited reported $-5.2M in EBIT versus $-620K a year earlier — a 734.7% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Chennai Meenakshi Multispeciality Hospital Limited sits lower the its sector benchmark ($2.4T) with a EBIT of $-5.2M. That is roughly 100.0% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

That compares with $-620K in the prior-year period — down 734.7% year over year. Sustained growth in EBIT can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Chennai Meenakshi Multispeciality Hospital Limited's EBIT evolved across reporting periods, while the comparison chart places CMMHOSP.BO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.